Skip Navigation and Go To Content
News from The University of Texas Health Science Center at Houston

Stories from The University of Texas Health Science Center at Houston (UTHealth)

Navigation and Search

Health


Health care experts propose 6 principles to follow when switching electronic health record systems

Photo of person looking at computer. (Photo by Getty Images)

January 25, 2022

As health care evolves over the next 10 years, many providers will switch out their current electronic health record (EHR) system for a new one due to health system mergers or to keep up with the trends. Because EHR switches can cause care disruptions, researchers with The University of Texas Health Science Center at Houston (UTHealth Houston), U.S. Department of Veterans Affairs, and Baylor College of Medicine suggest following six key guidelines for an easy and safe transition.


Surgery, care allow child born with cleft lip and palate to blow bubbles and more

Jae Beltran, now 7, sees pediatric plastic surgeon Matthew Greives, MD, for annual checkups to monitor his cleft lip and palate. (Photo courtesy of Sonia Estrada)

January 24, 2022

The first time Sonia Estrada saw her son Jae blow a bubble, it brought tears to her eyes. The seemingly simple act marked a major milestone for the now 7-year-old Jae, who was born with a cleft lip and palate – birth defects that occur when a baby’s lip or mouth do not form properly during pregnancy.

But thanks to pediatric plastic surgeon Matthew Greives, MD, director of the Texas Cleft-Craniofacial Team, Jae has progressed tremendously and remains on the right track with his medical care.




New model reveals achieving an 80% HPV vaccination rate could eliminate nearly 1 million cases of male oropharyngeal cancer this century

Photo of young man getting a shot. (Photo by Getty Images)

December 15, 2021

A nationwide effort to adequately vaccinate 8 in 10 adolescents against the human papillomavirus (HPV) could prevent 934,000 cases of virus-associated, male oropharyngeal cancer over this century, reported investigators at The University of Texas Health Science Center at Houston (UTHealth Houston) School of Public Health in The Lancet Regional Health—Americas.




Drug used to prevent miscarriage increases risk of cancer in offspring

Photo of pregnant woman holding pill. (Photo by Getty Images)

November 9, 2021

Exposure in utero to a drug used to prevent miscarriage can lead to an increased risk of developing cancer, according to researchers at The University of Texas Health Science Center at Houston (UTHealth Houston).

The study was published today in the American Journal of Obstetrics and Gynecology.




Page 1 of 33

More headlines »

Search UTHealth News

Use the form below to perform a new search.

Give to UTHealth